Patent · US Active

Anti-C1s antibodies and uses thereof

US11958899B2 · kind B2 · utility

0Cited by

11References

22Claims

0Family size

Inventors

BUXIN CHEN · San Marcos, US
Lei Huang · Duluth, US
Xin Du · Schaumburg, US

Key dates

Filing date	Jun 28, 2022
Grant date	Apr 16, 2024
Priority date	—
Expiry date	Jul 21, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies and antigen-binding fragments thereof that bind C1s and inhibit C1s activity and modulate the activity of at least one component in the classical pathway (CP) of complement activation, and methods for treating complement-mediated disorders using anti-C1s antibodies and fragments, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.